Literature DB >> 19667239

Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease.

Eloi Marijon1, David S Celermajer, Muriel Tafflet, Saïd El-Haou, Dinesh N Jani, Beatriz Ferreira, Ana-Olga Mocumbi, Christophe Paquet, Daniel Sidi, Xavier Jouven.   

Abstract

BACKGROUND: Early case detection is vital in rheumatic heart disease (RHD) in children to minimize the risk of advanced valvular heart disease by preventive measures. The currently utilized World Health Organization (WHO) criteria for echocardiographic diagnosis of subclinical RHD emphasize the presence of pathological valve regurgitation but do not include valves with morphological features of RHD without pathological regurgitation. We hypothesized that adding morphological features to diagnostic criteria might have significant consequences in terms of case detection rates. METHODS AND
RESULTS: We screened 2170 randomly selected school children aged 6 to 17 years in Maputo, Mozambique, clinically and by a portable ultrasound system. Two different echocardiographic sets of criteria for RHD were assessed: "WHO" (exclusively Doppler-based) and "combined" (Doppler and morphology-based) criteria. Independent investigators reviewed all suspected RHD cases using a higher-resolution, nonportable ultrasound system. On-site echocardiography identified 18 and 124 children with suspected RHD according to WHO and combined criteria, respectively. After consensus review, 17 were finally considered to have definite RHD according to WHO criteria, and 66 had definite RHD according to combined criteria, giving prevalence rates of 7.8 (95% confidence interval, 4.6 to 12.5) and 30.4 (95% confidence interval, 23.6 to 38.5) per 1000 children, respectively (P<0.0001, exact McNemar test).
CONCLUSIONS: Important consideration should be given to echocardiographic criteria for detecting subclinical RHD because the number of cases detected may differ importantly according to the diagnostic criteria utilized. Currently recommended WHO criteria risk missing up to three quarters of cases of subclinically affected and therefore potentially treatable children with RHD.

Entities:  

Mesh:

Year:  2009        PMID: 19667239     DOI: 10.1161/CIRCULATIONAHA.109.849190

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  32 in total

1.  Prevalence of rheumatic heart disease in children and young adults in Nicaragua.

Authors:  John A Paar; Nubia M Berrios; John D Rose; Mercedes Cáceres; Rodolfo Peña; Wilton Pérez; Mario Chen-Mok; Erik Jolles; James B Dale
Journal:  Am J Cardiol       Date:  2010-04-27       Impact factor: 2.778

Review 2.  World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline.

Authors:  Bo Reményi; Nigel Wilson; Andrew Steer; Beatriz Ferreira; Joseph Kado; Krishna Kumar; John Lawrenson; Graeme Maguire; Eloi Marijon; Mariana Mirabel; Ana Olga Mocumbi; Cleonice Mota; John Paar; Anita Saxena; Janet Scheel; John Stirling; Satupaitea Viali; Vijayalakshmi I Balekundri; Gavin Wheaton; Liesl Zühlke; Jonathan Carapetis
Journal:  Nat Rev Cardiol       Date:  2012-02-28       Impact factor: 32.419

3.  Echocardiographic screening for rheumatic heart disease-some answers, but questions remain.

Authors:  Marc G W Rémond; Graeme P Maguire
Journal:  Transl Pediatr       Date:  2015-07

4.  Communication of novel concepts.

Authors:  Paul Schoenhagen
Journal:  Cardiovasc Diagn Ther       Date:  2012-03

5.  Focus on non-communicable diseases: an important agenda for the African continent.

Authors:  Ana Olga Mocumbi
Journal:  Cardiovasc Diagn Ther       Date:  2013-12

Review 6.  Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis.

Authors:  Liesl Zühlke; Bongani M Mayosi
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

Review 7.  Rheumatic heart disease: current status of diagnosis and therapy.

Authors:  Ferande Peters; Ganesan Karthikeyan; Jessica Abrams; Lorrein Muhwava; Liesl Zühlke
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

8.  Streptococcal pharyngitis in children with painful throat: missed opportunities for rheumatic heart disease prevention in endemic area of Africa.

Authors:  Geoffrey Madeira; Daniel Chicavel; Alcides Munguambe; José Langa; Ana Mocumbi
Journal:  Cardiovasc Diagn Ther       Date:  2017-08

Review 9.  Screening for rheumatic heart disease: current approaches and controversies.

Authors:  Kathryn Roberts; Samantha Colquhoun; Andrew Steer; Bo Reményi; Jonathan Carapetis
Journal:  Nat Rev Cardiol       Date:  2012-11-13       Impact factor: 32.419

10.  Use of Doppler echocardiography to support the decision to discontinue secondary prophylaxis for patients with rheumatic fever and normal cardiac auscultation.

Authors:  Fátima Derlene da Rocha Araújo; Eugênio Marcos de Andrade Goulart; Zilda Maria Alves Meira
Journal:  Pediatr Cardiol       Date:  2012-12-13       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.